... TARRYTOWN N.Y. Sept. 26 -- The National...NATT will use its two Centers for Disease Control and Prevention (CDC)... We have a national crisis because few people recognize or understand...Mr. Fenninger complimented the proactive efforts of the CDC forrecogn...

TARRYTOWN, N.Y., Sept. 26 /PRNewswire-USNewswire/ -- The National
Alliance for Thrombosis and Thrombophilia (NATT) today announced the award
of two major program grants totaling $1.35 million that will serve as
building blocks for its efforts to curb the unchecked devastating effects
caused each year to nearly one million Americans who develop a blood clot.

NATT will use its two Centers for Disease Control and Prevention (CDC)
grants to "launch a national wake-up call to promote public and healthcare
professional awareness of this serious medical condition that each year
kills nearly 300,000 Americans," explains NATT President Randy Fenninger.

"We have a national crisis because few people recognize or understand
the symptoms and risk factors of this silent killer. And even equally
startling, is that not enough of our nation's healthcare professionals have
a full understanding of the symptoms and the methods for treatment of this
life- threatening condition," he said. Complications from clotting,
occurring in more than half of those affected individuals, can often have
serious consequences - as is evident from an annual mortality rate that is
greater than the combined deaths from breast cancer, AIDS, and automobile
accidents.

Mr. Fenninger complimented the proactive efforts of the CDC for
recognizing the need to fund an all-out public and professional attack
against blood clotting disorders. The awards, he notes, "serve to further
support our national education and awareness work. This is a superb news
for all Americans at risk for blood clots, and a very proud moment for the
many volunteers who have worked so hard to move NATT from a board room
dream to a now nationally respected community-based advocacy organization
that does so much good."

Aiding the CDC's proactive funding efforts was a meeting held in May of
2006 by the U.S. Surgeon General who brought together national healthcare
and public leaders to discuss the serious problems surrounding blood clots
and clotting disorders. The general theme from this meeting is the
publication of "Call-to-Action" this fall by the U.S. Surgeon General to
improve education and awareness within the healthcare profession, as well
as the general public.

These facts, combined with a serious lack of awareness among the
public, constitute a significant public health problem that NATT has been
battling since its inception in 2003. NATT Executive Director Alan
Brownstein explained that a national initiative called "Stop-The-Clot,"
will now be launched. The multi-tiered program, one of two receiving
funding awards from the CDC, will focus its education and awareness efforts
on such objectives as:

-- Enhancement of NATT's successful patient seminars into a nationally

The CDC also awarded funding for a nurses and non-physician healthcare
professionals' education project that will specifically address the areas
of blood clot prevention, diagnosis, treatment and management. NATT's
Medical And Scientific Advisory Board (MASAB) Chairman Dr. Stephan Moll,
director of the University of North Carolina - Chapel Hill Thrombophilia
Program, expressed his board's delight regarding the CDC awards. "I commend
the CDC on their efforts to respond to this extreme health issue in such a
proactive manner through funding these programs instituted by NATT," he
said.

Dr. Moll noted that the healthcare professionals' education project is
deemed an essential element in the fight against blood clots. "Improving
the content and delivery of health information/education by nurses and
other non- physicians," he said, "provides an educational and training
aspect to a critical part of a patient's healthcare and wellness."

The program, Dr. Moll explained, will be delivered nationally through
the utilization of evidence-based teaching methods in small group sessions
led by trained faculty. The program's ultimate goal is to prevent secondary
conditions in people with clotting disorders by improving their access to
knowledgeable healthcare providers.

NATT will collaborate with many organizations in its development of a
12- region training program. Patients will be reached throughout the U.S.
network of the 140-federally funded Hemophilia Treatment Centers, the CDC
Pilot Thrombophilia Centers and through participants of the Anticoagulation
Forum.

(For More Information regarding the National Alliance for Thrombosis
and Thrombophilia and/or their national programs, please contact Alan
Brownstein at (917) 209-2000, apbrownstein@msn.com, or NATT President Randy
Fenninger (202) 833-0007, or log on to http://www.nattinfo.org. NATT is a 501c3
national volunteer community-based organization, which welcomes support
through involvement and/or donations. Further information can also be
obtained from NATT's Medical and Scientific Advisory Board chairman Dr.
Stephan Moll, University of North Carolina at Chapel Hill at (919) 966-3311
or smoll@med.unc.edu.)

(Date:12/8/2016)... 2016 OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ... cancer immunotherapies, today announced financial results for the ... are delivering on our commitment to address an ... We are pleased with the early clinical response ... we are focused on advancing our lead program ...

(Date:12/8/2016)... 2016 AskLinkerReports.com has published a report ... Amyloglucosidase Industry 2016 Market Research Report. From a basic outline ... overview are all covered in the report. This report projects ... analysis of the Amyloglucosidase industry. ... , , ...

(Date:12/6/2016)... DALLAS , Dec. 6, 2016 ... criminal justice technology solutions for public safety, investigation, ... (PEP) jointly announced today a five (5) year ... exclusive agreement to expand the rehabilitation and reentry ... PEP History Established in 2004, the Prison ...

(Date:11/30/2016)... , Nov. 30, 2016 Not many of us realize that we ... of recovery so we need to do it well. Inadequate sleep levels have been ... blood pressure, stroke, diabetes, and even cancer. Maybe now is the best ... that could help them to manage their sleep quality? ... ...

(Date:11/29/2016)... Nearly one billion matches per second with DERMALOG,s high-speed AFIS ... ... DERMALOG is Germany's largest Multi-Biometric supplier: The ... Identification Systems) ... Germany's largest Multi-Biometric supplier: The company's Fingerprint Identification System is part of ...